Oncopeptides AB - ESG Rating & Company Profile powered by AI
This report of Oncopeptides AB employs information from across the web and also from available filings by Oncopeptides AB. Comprehensive ESG assessment of Oncopeptides AB are reached by logging in. Alternative corporations in the rating peer group for Oncopeptides AB are shownin the table.
Oncopeptides AB in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.0; made up of an environmental score of 4.0, social score of 3.2 and governance score of 4.8.
4.0
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
989 | Spectrum Pharmaceuticals Inc | 4.1 | High |
989 | Tricida Inc | 4.1 | High |
1004 | Oncopeptides AB | 4.0 | High |
1004 | Can B Corp | 4.0 | High |
1004 | CLS Holdings USA Inc | 4.0 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Oncopeptides AB have an accelerator or VC vehicle to help deliver innovation?
Does Oncopeptides AB disclose current and historical energy intensity?
Does Oncopeptides AB report the average age of the workforce?
Does Oncopeptides AB reference operational or capital allocation in relation to climate change?
Does Oncopeptides AB disclose its ethnicity pay gap?
Does Oncopeptides AB disclose cybersecurity risks?
Does Oncopeptides AB offer flexible work?
Does Oncopeptides AB have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Oncopeptides AB disclose the number of employees in R&D functions?
Does Oncopeptides AB conduct supply chain audits?
Does Oncopeptides AB disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Oncopeptides AB conduct 360 degree staff reviews?
Does Oncopeptides AB disclose the individual responsible for D&I?
Does Oncopeptides AB disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Oncopeptides AB disclose current and / or historical scope 2 emissions?
Does Oncopeptides AB disclose water use targets?
Does Oncopeptides AB have careers partnerships with academic institutions?
Did Oncopeptides AB have a product recall in the last two years?
Does Oncopeptides AB disclose incidents of discrimination?
Does Oncopeptides AB allow for Work Councils/Collective Agreements to be formed?
Has Oncopeptides AB issued a profit warning in the past 24 months?
Does Oncopeptides AB disclose parental leave metrics?
Does Oncopeptides AB disclose climate scenario or pathway analysis?
Does Oncopeptides AB disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Oncopeptides AB disclose the pay ratio of women to men?
Does Oncopeptides AB support suppliers with sustainability related research and development?
Does Oncopeptides AB disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Oncopeptides AB reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Oncopeptides AB involved in embryonic stem cell research?
Does Oncopeptides AB disclose GHG and Air Emissions intensity?
Does Oncopeptides AB disclose its waste policy?
Does Oncopeptides AB report according to TCFD requirements?
Does Oncopeptides AB disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Oncopeptides AB disclose energy use targets?
Does Oncopeptides AB disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Oncopeptides AB have a policy relating to cyber security?
Have a different question?
Potential Risks for Oncopeptides AB
These potential risks are based on the size, segment and geographies of the company.
Oncopeptides AB (publ), a biotech company, develops pharmaceuticals drugs for the treatment of cancer in the United States, Europe, and internationally. Its lead product candidate is melflufen, an anti-cancer peptide drug conjugate for the treatment of relapsed refractory multiple myeloma in adult patients. Oncopeptides AB (publ) was incorporated in 2000 and is headquartered in Stockholm, Sweden.